ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2836 www.acadia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 17th, 2025 9:05 pm
Acadia Pharmaceuticals: Billion-Dollar Milestone and Global Expansion in 2025 - Jan 14th, 2025 6:10 pm
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference - Jan 14th, 2025 2:05 pm
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome - Jan 14th, 2025 2:00 pm
Is ACADIA Pharmaceuticals (ACAD) the Best Medical Stock to Buy Under $20? - Jan 12th, 2025 2:33 pm
Further weakness as ACADIA Pharmaceuticals (NASDAQ:ACAD) drops 5.2% this week, taking five-year losses to 61% - Jan 8th, 2025 7:58 pm
Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing - Jan 2nd, 2025 7:58 am
Acadia Pharmaceuticals Set to Join S&P SmallCap 600 - Dec 30th, 2024 10:37 pm
Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 - Dec 19th, 2024 9:05 pm
High Growth Tech Stocks To Watch In December 2024 - Dec 12th, 2024 6:03 pm
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million - Dec 11th, 2024 9:05 pm
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer - Dec 9th, 2024 2:00 pm
Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term - Dec 3rd, 2024 2:50 pm
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options - Dec 3rd, 2024 1:32 pm
ACAD Signs License Deal With Saniona for Rights to Neurology Drug - Nov 27th, 2024 3:06 pm
Acadia signs agreement with Saniona to commercialise SAN711 - Nov 27th, 2024 12:06 pm
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 - Nov 26th, 2024 9:05 pm
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Nov 21st, 2024 9:05 pm
High Growth Tech Stocks to Watch in November 2024 - Nov 13th, 2024 6:03 pm
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock - Nov 12th, 2024 2:50 pm